Fujifilm’s New Holly Springs Pharma Hub Poised to Boost J&J and Regeneron Production—A Strategic Win for Investors Eyeing Biotech Growth

New drug plant boosts US biologic manufacturing capacity

In the high-stakes world of biopharmaceuticals, Fujifilm Biotechnologies is setting a new gold standard with its mammoth $3 billion biologics manufacturing complex in Holly Springs, North Carolina. Spanning four buildings connected by a hallway as … Read more

Moderna’s Q2 2025 Earnings Reveal Growth Trajectory: What Investors Need to Know About the Biotech Giant’s Financial Health and Future Prospects

Moderna (MRNA) Q2 2025 earnings

Moderna’s 2025 Outlook Shift: What Investors Need to Know Beyond the Headlines Moderna’s recent earnings report sent ripples through the biotech sector, with shares tumbling over 9% after the company lowered the high end of … Read more

Space Startup Varda Secures $187M to Revolutionize Drug Manufacturing in Orbit—A Game-Changer for Biotech Investors Eyeing Space-Based Innovation

Space startup Varda raises $187 million to make drugs in orbit

Varda Space Industries Just Secured $187M to Revolutionize Drug Manufacturing in Orbit — Here’s Why Investors Should Pay Close Attention The space economy is rapidly evolving, and one of the most fascinating frontiers is pharmaceutical … Read more

June Sees Family Offices Boost Investments: Why Biotech and Pharma Are the New Hotspots for Savvy Investors

Family offices ramp up deals in June with bets on biotech and pharma

June’s Surge in Ultra-Rich Family Office Investments: A New Playbook for Savvy Investors After a sluggish spring, the ultra-wealthy investment firms—family offices managing vast fortunes—revved up deal-making engines in June, making 60 direct investments, according … Read more